<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04167111</url>
  </required_header>
  <id_info>
    <org_study_id>646-19</org_study_id>
    <nct_id>NCT04167111</nct_id>
  </id_info>
  <brief_title>Pilot Study- Treat to Target Vitamin D in End Stage Renal Disease</brief_title>
  <official_title>Pilot Study- Treat to Target Vitamin D in End Stage Renal Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Nebraska, Omaha</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nebraska</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pilot study to test the feasibility of adjusting doses based on a prespecified algorithm to
      reach a 6 month 25(OH)D level of 35-50 ng/ml in end stage renal disease patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pilot study to test the feasibility of adjusting doses based on a prespecified algorithm to
      reach a 6 month 25(OH)D level of 35-50 ng/ml in end stage renal disease patients.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Subjects will be started on Vitamin D3 4000 per day or 2400 IU per day at baseline and based on 3 month 25(OH)D levels, will be adjusted to a different vitamin D dose if needed</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>25(OH)D level</measure>
    <time_frame>6 months</time_frame>
    <description>25(OH)D level</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Chronic Kidney Diseases</condition>
  <arm_group>
    <arm_group_label>Vitamin D 4000</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>At baseline, if subjects 25(OH)D levels are 12-19.9, they will be started on 4000 IU per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D 2400</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>At baseline, if subjects 25(OH)D levels are 20-30, they will be started on 2400 IU per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cholecalciferol</intervention_name>
    <description>Vitamin D</description>
    <arm_group_label>Vitamin D 2400</arm_group_label>
    <arm_group_label>Vitamin D 4000</arm_group_label>
    <other_name>Vitamin D3</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  likely be able to complete the study, &gt;3 months on hemodialysis, receiving standard of
             care through their nephrologist.

        Exclusion Criteria:

          -  on peritoneal dialysis, allergy to vitamin D, liver disease, intestinal disorders that
             interfere with vitamin D absorption, taking vitamin D &gt;800 IU per day, 25(OH)D level
             &gt;30 ng/ml, glucocorticoids, anticonvulsants or drug therapies for osteoporosis,
             pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laura Graeff-Armas, MD,MS, PhD</last_name>
    <phone>402-559-6310</phone>
    <email>laura.armas@unmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Nebraska</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198-4130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 14, 2019</study_first_submitted>
  <study_first_submitted_qc>November 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2019</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nebraska</investigator_affiliation>
    <investigator_full_name>Laura Armas MD, MS</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

